KDA Group, Inc. engages in the provision of solutions and services to the pharmaceutical market. The company is headquartered in Thetford Mines, Quebec. The company went IPO on 2009-09-09. The firm operates through Pharmaceutical Technology segment. The company is focused on developing its technological products across four different platforms: KRX Medical, KRX Dental, KRX Cannabinoid and Adherize (ADRX). The KRX Dental is an electronic prescription platform assisting dentists in their practice. The KRX Medical is an electronic prescription platform assisting physicians in their practice. The KRX Cannabinoid is an electronic prescription platform assisting physicians in their practice when prescribing medical cannabis. The ADRX platform offers content allowing healthcare professionals (doctors and pharmacists) to virtually present various information. The platform includes various modules: Intelligent dialogue system, online questionnaire, pharmacist dashboard, developed algorithms, and a patient portal.
Follow-Up Questions
Who is the CEO of KDA Group Inc?
Mr. Marc Lemieux is the Chairman of the Board of KDA Group Inc, joining the firm since 2015.
What is the price performance of KDAGF stock?
The current price of KDAGF is $0.1662, it has decreased 0% in the last trading day.
What are the primary business themes or industries for KDA Group Inc?
KDA Group Inc belongs to Health Care industry and the sector is Health Care
